submit to the journals

Obesity and Weight Management Journal Articles, Videos And Insights

Obesity and Weight Management:FEATURED Articles

flipper_slider

Obesity and Weight Management: Latest Articles

Obesity and Weight Management: INSIGHTS

The touchENDOCRINOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of endocrinology:

Insight
New Tool to Assess Bone Health in Patients with Obesity Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Group Director and Advisory Editor, Touch Medical Media, Reading, UK
-Insights into the BMD/BMI tool for assessing bone health, presented at AACE, Boston, US, 16–20 May 2018
Insight
How Weight is Lost Following Bariatric Surgery Affects the Reversal of Type 2 Diabetes Stefan Amisten, Senior Medical Writer, Touch Medical Media, UK
Jeremy Betts, Account Director and Advisory Editor, Touch Medical Media, UK
-Insights into STAMPEDE clinical trial from the Cleveland Clinic, presented at AACE, Boston, US, 16–20 May 2018
Insight
Lipodystrophy – an Insight into a Rare Condition with Severe Metabolic Consequences Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Group Director and Advisory Editor, Touch Medical Media, UK
-Insights into lipodystrophies, presented at the ECE congress, Barcelona, Spain, Monday 21 May 2018

Obesity and Weight Management:FEATURED VIDEOS

Editor's choice

Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies. Questions: 1. Why is cholesterol of interest for metabolic health and disease? (0:07) 2. Is cellular cholesterol toxicity and type 2 diabetes risk supported by clinical findings? (0:50) 3. Are there data that explain the incidence of increased type 2 diabetes risk with statin therapy? (1:27) 4. How does pitavastatin differ in having a favorable impact on metabolic health? (3:18) View the full article here. Speaker disclosures: Jeffrey S Elmendorf has nothing to declare in relation to this video interview. Support: The publication of this video was supported by Kowa Pharmaceuticals America who was given the opportunity to review the video for scientific accuracy before publication. Any resulting changes were made at the author’s/authors’ discretion.
Professor Stumvoll discusses his "Meet the Expert" session focussing on two patients with partial lipodystrophy. Speaker's disclosures: Speaker fees from Aegerion. This video is intended for health care professionals. Information for patients and carers can be found here Product information on metreleptin is available here Adverse events should be reported to Aegerion by email: Medinfo.emea@aegerion.com or by telephoning the free phone number: 00800 234 37466 Filmed at the European Association for the Study of Diabetes (EASD) annual meeting, Berlin, Germany, 2018

Obesity and Weight Management:Latest Videos

Video List based on Category on Node Page

Latest Videos

Behind insulin resistance: debugging the endocrine system. How to tackle leptin deficiency in lipodystrophies. Speaker's disclosures: Julia von Schnurbein received speaker’s fees from Aegerion, and she is a consultant to Rhythm Pharmaceuticals. Elif Oral is a consultant to Aegerion...
Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies. Questions: 1. Why is cholesterol of interest for metabolic health and disease? (0:07) 2. Is cellular cholesterol toxicity and type 2 diabetes risk supported by clinical...
Professor Stumvoll discusses his "Meet the Expert" session focussing on two patients with partial lipodystrophy. Speaker's disclosures: Speaker fees from Aegerion. This video is intended for health care professionals. Information for patients and carers can be found here Product...
Julia von Schnurbein discusses the latest advances in Myalepta and patients with lipodystrophies in Europe. Questions: 1. How can diabetologists recognise patients with lipodystrophies and Myalepta? (0:12) 2. What will it mean for patients with lipodystrophy that Myalepta is now available in...
Professor Oral summarises her key take home messages from her Aegerion-sponsored satellite symposium. Speaker's disclosures: Professor Oral is a consultant to Aegerion Pharmaceuticals with approved fee, has carried out research and consulting work for Akcea Therapeutics/Ionis Pharmaceuticals,...
Dr Giovanni Ceccarini discusses the key take-home messages from his Aegerion-sponsored Meet the Experts session at EASD 2018, where he focused on studies and therapeutics for patients with generalised lipodystrophy, and the effect of leptin and leptin-based treatment. Speaker's disclosures: Dr...

LATEST TWEETS

Conference Highlights